BRINOS [Xylometazoline] 5 mg/10 ml Nasal spray
BRINOS
instructions for medical use of the medicinal product
Tradename
Brinos, Brinos
International non-proprietary name
Xylometazoline, Xylometazoline
Composition
10 ml of the drug contains:
active ingredient: xylometazoline hydrochloride 5 mg or 10 mg
excipients: sodium chloride, potassium dihydrogen phosphate, disodium hydrogen phosphate, methylparaben, propylparaben, water for injection.
Dosage form, dosage
Nasal spray, 0.05%, 0.1%
Pharmacotherapeutic group
A decongestant is a vasoconstrictor (alpha-adrenergic agonist).
Pharmacological properties
Pharmacodynamics
Xylometazoline belongs to the group of local vasoconstrictors (decongestants) with alpha-adrenomimetic activity, causes narrowing of the blood vessels of the nasal mucosa, thus eliminating swelling and hyperemia of the nasal mucosa, restores the patency of the nasal passages, facilitates nasal breathing.
The effect of the drug occurs within a few minutes after its application and lasts up to 10 hours.
Pharmacokinetics
When applied topically, xylometazoline is practically not absorbed, so its plasma concentrations are very low (not determined by modern analytical methods).
Indications for use
To reduce swelling of the mucous membrane of the nasopharynx and secretions in acute allergic rhinitis, acute respiratory infections with rhinitis, sinusitis, hay fever, otitis media. Preparation of the patient for diagnostic manipulations in the nasal passages.
Contraindications
Hypersensitivity to the components of the drug; concomitant use of monoamine oxidase (MAO) inhibitors, tricyclic and tetracyclic antidepressants or other drugs that can cause an increase in blood pressure; arterial hypertension, tachycardia; severe atherosclerosis; glaucoma; atrophic rhinitis; surgical interventions on the meninges (in history); children's age up to 2 years for the use of a 0.05% solution and up to 6 years for a 0.1% solution.
With caution - diseases of the cardiovascular system, including coronary heart disease (angina pectoris); prostatic hyperplasia; thyrotoxicosis; diabetes; pheochromocytoma; porphyria; in patients with hypersensitivity to adrenomimetics, accompanied by symptoms of insomnia, dizziness, arrhythmia, tremor and increased blood pressure.
Dosage and administration
Intranasally.
Adults and children over 6 years old 1 injection of a 0.1% solution of the drug in each nasal passage 2-3 times a day.
Children aged 2 to 6 years apply a 0.05% solution of the drug, 1 injection into each nasal passage 1-2 times a day.
Do not use the drug more than 3 times a day. The course of treatment should not exceed 5-7 days.
Special instructions and precautions
Before use, clean the nasal passages. Should not be used for more than 7 days.
In colds, in cases where crusts form in the nose, it is preferable to prescribe in the form of a gel.
Influence on the ability to drive vehicles and mechanisms
Use during pregnancy and during breastfeeding
During pregnancy and during breastfeeding, it should be used only after a thorough assessment of the risk-benefit ratio for the mother and fetus, it is not allowed to exceed the recommended doses.
Interaction with other drugs
Incompatible with MAO inhibitors and tricyclic antidepressants.
Side effect
With frequent and / or prolonged use: irritation and / or dryness of the mucous membrane of the nasopharynx, burning, paresthesia, sneezing, hypersecretion, swelling of the nasal mucosa, palpitations, tachycardia, arrhythmia, increased blood pressure, vomiting, headache, insomnia, blurred vision , fatigue and depression (with prolonged use of high doses).
If any of the side effects listed in the instructions get worse, or if you notice any other side effects not listed in the instructions, tell your doctor.
Overdose
Symptoms: decrease in body temperature, bradycardia, increased blood pressure.
Treatment: symptomatic.
Storage conditions
Store in a cool place below 30°C.
Keep out of the reach of children.
Best before date
3 years. Do not use after the expiry date stated on the packaging.
Holiday conditions
Without recipe.
Release form
1 bottle with a spray cap and a protective cap of 10 ml, together with instructions for use in a cardboard box.

![BRINOS [Xylometazoline] 5 mg/10 ml Nasal spray BRINOS [Xylometazoline] 5 mg/10 ml Nasal spray](https://livemedicine.biz/image/cache/catalog/upload/Brinos_005-1000x1000.jpg)